Healthcare provider profile · identity verified

Robert Michael Dini

Family Practice · FEDERAL WAY, WA · NPI 1124103924

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	420	133
Amlodipine Besylate	Amlodipine Besylate	303	80
Lisinopril	Lisinopril	277	81
Levothyroxine Sodium	Levothyroxine Sodium	207	58
Losartan Potassium	Losartan Potassium	199	61
Metformin Hcl	Metformin Hcl	194	48
Oxycodone Hcl	Oxycodone Hcl	191	20
Omeprazole	Omeprazole	186	42
Gabapentin	Gabapentin	159	41
Metoprolol Succinate	Metoprolol Succinate	159	41
Hydrochlorothiazide	Hydrochlorothiazide	155	55
Trazodone Hcl	Trazodone Hcl	152	33
Metformin Hcl Er	Metformin Hcl	140	41
Rosuvastatin Calcium	Rosuvastatin Calcium	129	35
Albuterol Sulfate Hfa	Albuterol Sulfate	114	42
Furosemide	Furosemide	113	26
Sertraline Hcl	Sertraline Hcl	110	24
Pantoprazole Sodium	Pantoprazole Sodium	98	26
Potassium Chloride	Potassium Chloride	91	25
Simvastatin	Simvastatin	90	26
Metoprolol Tartrate	Metoprolol Tartrate	89	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	11
Meloxicam	Meloxicam	76	18
Montelukast Sodium	Montelukast Sodium	76	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	19
Jardiance	Empagliflozin	71	19
Ozempic	Semaglutide	68	14
Aripiprazole	Aripiprazole	64	suppressed
Fluticasone Propionate	Fluticasone Propionate	64	20
Quetiapine Fumarate	Quetiapine Fumarate	62	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	62	12
Morphine Sulfate Er	Morphine Sulfate	61	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	60	15
Tamsulosin Hcl	Tamsulosin Hcl	60	20
Carvedilol	Carvedilol	57	17
Atenolol	Atenolol	56	16
Bupropion Xl	Bupropion Hcl	55	suppressed
Ketoconazole	Ketoconazole	55	11
Tramadol Hcl	Tramadol Hcl	53	15
Duloxetine Hcl	Duloxetine Hcl	52	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	50	suppressed
Glipizide	Glipizide	49	15
Oxybutynin Chloride Er	Oxybutynin Chloride	49	suppressed
Tizanidine Hcl	Tizanidine Hcl	49	18
Pravastatin Sodium	Pravastatin Sodium	48	15
Mirtazapine	Mirtazapine	47	suppressed
Famotidine	Famotidine	46	12
Alprazolam	Alprazolam	45	13
Citalopram Hbr	Citalopram Hydrobromide	44	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	21
Eliquis	Apixaban	43	11
Glipizide Er	Glipizide	43	16
Allopurinol	Allopurinol	42	14
Pregabalin	Pregabalin	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Xarelto	Rivaroxaban	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	37	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Lovastatin	Lovastatin	33	suppressed
Trulicity	Dulaglutide	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	18
Clonazepam	Clonazepam	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Felodipine Er	Felodipine	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	13
Ibuprofen	Ibuprofen	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Prednisone	Prednisone	25	suppressed
Baclofen	Baclofen	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Atrovent Hfa	Ipratropium Bromide	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Azithromycin	Azithromycin	13	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Probenecid	Probenecid	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Edarbi	Azilsartan Medoxomil	11	suppressed
Estradiol	Estradiol	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Prempro	Estrogen,con/M-Progest Acet	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Vilazodone Hcl	Vilazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error